Document Detail


Predictive markers for neoadjuvant chemotherapy in advanced squamous cell carcinoma of maxillary sinus: Preliminary report.
MedLine Citation:
PMID:  23146027     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Abstract Conclusion: ERCC 1 seems to be promising as a predictive marker for response to neoadjuvant chemotherapy (NAC) and early decision for surgery in advanced squamous cell carcinoma (SCC) of the maxillary sinus. Objectives: This study aimed to find a possible relation of ERCC1 or XRCC1 expression with response to NAC and prognosis in advanced SCC of the maxillary sinus. Methods: From 1998 to 2006, 17 patients with advanced SCC of the maxillary sinus received NAC at the Seoul National University Hospital. The expression of ERCC1 and XRCC1 was assessed by immunohistochemistry. Complete and partial remissions were categorized as the chemo-sensitive group. On the other hand, stable and progressive diseases were categorized as the chemo-resistant group. Results: Of these 17 patients, 1 had complete remission, 6 had partial remission, 4 had stable disease, and 6 had progression of disease. The 5-year survival rate was 40% for all 17 patients. The expression of ERCC1 and XRCC1 was not correlated with nodal or distant metastasis. With a cut-off value of 65%, patients with higher ERCC1 scores showed chemo-resistance and survival disadvantage over those with lower ERCC1 scores. However, XRCC1 did not show a significant effect on the response to NAC.
Authors:
Ik Joon Choi; Dong-Wan Kim; Dong-Young Kim; Chul Hee Lee; Chae-Seo Rhee
Related Documents :
12868857 - Usefulness of early-phase helical ct for detecting recurrent rectal cancer.
10661337 - Anal sphincter conservation for patients with adenocarcinoma of the distal rectum: long...
18083137 - Results of laparoscopic anterior resection for rectal adenocarcinoma: retrospective ana...
20541057 - Acr appropriateness criteria: local excision in early-stage rectal cancer.
18638757 - Epilepsy and primary cerebral tumours.
20070327 - A systematic review of folfoxiri chemotherapy for the first-line treatment of metastati...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-13
Journal Detail:
Title:  Acta oto-laryngologica     Volume:  -     ISSN:  1651-2251     ISO Abbreviation:  Acta Otolaryngol.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370354     Medline TA:  Acta Otolaryngol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Departments of Otorhinolaryngology, Korea Cancer Center Hospital.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Semi-transparent nanostructured films for imaging mass spectrometry and optical microscopy.
Next Document:  PDGFRalpha/beta and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinica...